EDWIGE TONYE: Open Payments
NPI 1114501269 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 37 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $434 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $157 |
| Teva Pharmaceuticals USA, Inc. | 9 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $109 |
| Otsuka America Pharmaceutical, Inc. | 6 | $108 |
| E.R. Squibb & Sons, L.L.C. | 3 | $103 |
| ABBVIE INC. | 3 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $61 |
| Alkermes, Inc. | 2 | $52 |
| Lundbeck LLC | 1 | $24 |
| Luye Pharma (USA) Ltd. | 1 | $18 |
Products named: INGREZZA, CAPLYTA, COBENFY, UZEDY, VRAYLAR, AUSTEDO XR, ABILIFY MAINTENA, ARISTADA.
Industry payments across NY — which companies pay providers there.
